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ABSTRACT
Wilms tumor (nephroblastoma) is rare in adults. We present a case of 28-year old female with Wilms tumor diagnosed 
with pre-operative abdominal magnetic resonance imaging, histopathological analysis and immunohistochemistry. 
She had relapse tumor two years after primary open radical nephrectomy. She was managed with chemotherapy with 
the ICE regimen (ifosfamide, carboplatin, and etoposide) for six cycles with partial response and excellent functional 
status. 
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ABSTRAK
Tumor Wilms (nefroblastoma) adalah kasus yang jarang ditemukan pada orang dewasa. Kami melaporkan satu kasus, 
pasien perempuan, 28 tahun dengan tumor Wilms yang didiagnosis dengan pemeriksaan magnetic resonance imaging 
pre-operasi, histopatologi, dan imunohistokimia. Pasien tersebut mengalami relaps dua tahun pasca-radikal 
nefrektomi. Pasien kemudian menjalani kemoterapi dengan regimen ICE (ifosfamid, karboplatin, dan etoposid) selama 
enam siklus dengan repons parsial dan status fungsional baik. 
Kata Kunci: nefroblastoma, tumor Wilms, dewasa, nefrektomi, kemoterapi
INTRODUCTION
Wilms tumor (nephroblastoma) was first described by Thomas F. Rance in 1.814 and histologically described by Carl Max Wilhelm Wilms in 1899.1 It is the 
second most common intraabdominal cancer of childhood, it contributes approximately 
6% of all pediatric cancers and more than 95% of all kidney tumors in the pediatric 
age group.2 In adults, Wilms tumor represents about 1% of all renal tumors. This 
usually result in treatment delay and poor treatment outcome due to an unexpected 
diagnosis and unfamiliarity of adult oncologist with Wilms tumor.3 Standard treatment 
for Wilms tumor in Indonesia consists of surgery, chemotherapy and external beam 
radiation therapy. We report a case of a female adult presenting with unilateral 
Wilms tumor who underwent primary surgical excision and subsequent chemotherapy 
for relapse.
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CASE REPORT
A 28-year old female presented with a progressive 
enlargement of right lower quadrant abdominal 
mass. The patient underwent explorative laparotomy 
in a district hospital under a pre-operative diagnosis 
of solid right ovarium tumor. Intraoperatively, the 
female reproductive organs (uterus, ovaries, and 
fallopian tubes) were normal. A large solid lobulated 
mass was found on the right paracolic area extending 
from right hypochondrium until right inguinal. A 
biopsy of the mass was performed. Histopathology 
result was reviewed and immunohistochemistry 
staining was performed by our pathologist. The 
pathology analysis was carcinoid tumor (IHC positive 
for NSE and cytokeratin). Abdominal MRI revealed 
a discrete cystic mass with solid and fatty tissue 
component on the right kidney with a size of 20.6 x 
14.8 cm. There was no signs of renal vein or vena 
cava involvement, enlarged lymph nodes, or metastasis 
(figure 1). Chest x-ray also showed no signs metastasis. 
Pre-operative laboratory examination was unremarkable 
except for a high level of LDH 1029 U/L.
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Figure 1: Pre-operative MRI, (A) T1-weighted + contrast axial view; (B) 
T2-weighted coronal view; (C) T1-weighted + contrast sagittal view.
A right open radical nephrectomy was performed. 
The patient was stable and discharged three days 
post-op. Histopathology and IHC result was 
nephroblastoma (positive for cytokeratin and NSE 
and negative for desmin and vimentin) with favorable 
histology (figure 2). Regular follow up after surgery 
was unremarkable, with no relapse on physical 
examination or imaging studies. However, two years 
after surgery, abdominal ultrasonography (US) 
revealed a mass on right renal fossa extending 
towards the right iliac region with the size of 11.7 
x 11.4 cm. The patient then underwent chemotherapy 
by our medical oncologist using pediatric 
chemotherapy protocol (ifosfamide, carboplatin, 
etoposide) for six cycles. She experienced fatigue, 
nausea, vomiting and episodes of pancytopenia 
between chemotherapy with frequent manifestation 
of gum bleeding but briefly recovered with G-CSF 
analog, blood transfusions, and adequate broad-
spectrum antibiotics.
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Figure 2: Results of histopathology and immunohistochemistry (IHC) 
examination. (A) Blastemal cells (magnification, x100). (B) Positive 
IHC staining with Cytokeratin (magnification, x100). (C) Negative IHC 
staining with Desmin (magnification, x100). (D) Negative IHC staining 
with Vimentin (magnification, x100). (E) Positive IHC staining with NSE 
(magnification, x100).
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Figure 3: Follow-up abdominal ultrasound, (A) No metastasis on the liver, 
no mass on the right renal fossa; (B) Left kidney was normal; (C) Nodular 
mesenterial mass.
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Six-month follow-up after six cycles of chemotherapy 
showed no palpable mass on physical examination, 
a 90 Karnofsky score, and US showed no residual 
mass on right renal fossa, no signs of metastasis, 
and the contralateral kidney was normal. However, 
there was a nodular mesenterial mass with the size 
of 9.9 x 6.52 cm (which was smaller compared to 
previous imaging performed three months earlier 
– figure 3). This nodular mesenterial mass was detected 
on the right iliac region, outside the right renal 
fossa. Chest x-ray no sign of metastasis. Laboratory 
examination was unremarkable. Chemotherapy was 
stopped and she was planned for a follow-up CT-
scan in six months.
DISCUSSION
Wilms tumor, also known as nephroblastoma is 
the most common kidney tumor in the pediatric 
population.2 In adults, Wilms tumor is a rare disease 
with an incidence rate as low as 1%. Treatment 
delay may occur because it is unexpected to found 
this tumor in an adult population.3, 4 In a study by 
the Society of Pediatric Oncology (SIOP), the mean 
time to relapse is approximately two years with an 
overall survival of 83% and disease-free survival of 
57%.4 In addition, it has been found that older age 
is associated with a higher risk of relapse.3 Metastasis 
occurs in 10% and 29% in children and adults 
respectively. Later stage were found in adults 
compared to children (stage III and IV in 50% adults 
compared to 30% children). In patients with relapse, 
the three-year survival is about 30%.5 Staging is 
based on the anatomic stent of the tumor.5, 6 There 
are two main staging systems: a prechemotherapy, 
surgery-based system (by National Wilms Tumor 
Study Group – NWTSG) and post-chemotherapy 
based system (by SIOP). Although about 95% of 
Wilms tumor may be predicted with imaging 
(ultrasound, computed tomography – CT, and magnetic 
resonance imaging – MRI), however in adults, CT 
or MRI may aid in diagnosis.1,7 Immunohistochemistry 
may prove useful in the diagnosis of Wilms tumor, 
with positivity for cytokeratin, NSE, and vimentin.6 
There is no standard therapy for treating patients 
with adult Wilms tumor. Some author suggested to 
treat adult Wilms tumor with the same protocols 
used in children which incorporates multimodal 
approach: surgery, chemotherapy, and radiation.4, 8 
To date, primary radical nephrectomy followed by 
chemotherapy is the only treatment strategy for 
patients older than 16 years.4 Our patient underwent 
surgery and was disease free for two years of 
intensive follow-up. However, due to relapsed disease, 
chemotherapy was initiated. She received ICE 
(ifosfamide, carboplatin, and etoposide) chemotherapy 
protocol for pediatric patients with adjusted doses. 
Ifosfamide was administered at a dose of 1800 mg/
m2/day for five days, carboplatin 400 mg/m2/day for 
two days, and etoposide 100 mg/m2/day for five 
days. Patients also received intravenous hydration 
and mesna during the five-day course of ifosfamide. 
The chemotherapy cycle supposed to repeat for 
every 21 days but in our patient, there were delays 
due to episodes of chemotherapy toxicity. 
Adult Wilms tumor in seems to be identical to 
that in the pediatric population and seems to 
respond to the same protocols used in children. 
However, the rate of treatment-related hematologic 
and non-hematologic toxicity appears to be higher 
in adult patients.4 Previous studies showed that the 
combined use of ICE chemotherapy protocol has 
resulted in an overall response rate over 80% in 
pediatric solid tumors with 27% complete remission 
and 55% partial response. It has an overall survival 
rate and progression-free survival rate of 63%.5,9 
SIOP recommended an administration of chemotherapy 
4 weeks before surgery.4 Indefinite pre-operative 
diagnosis made us leave out this step and proceed 
with surgery, and thus manage the relapse disease 
with ICE chemotherapy regimen which resulted in 
a partial response after six cycles. Commonly 
encountered toxicity with this regiment were 
pancytopenia, fatigue, nausea, and vomiting. 
Wilms tumor is the most common kidney tumor 
in children may also be encountered in adults. Primary 
surgery with chemotherapy is the standard management 
in adults. In the event of relapse, ICE chemotherapy 
regimen provide an overall high response rate.
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